The developer of the treatment, Geron Corporation, said the FDA had removed a clinical hold on its GRNOPC1 therapy.
It hopes to start testing GRNOPC1 on humans by year's end, enrolling eight to 10 patients across the US.
The trial will take about two years, with each patient being studied for one year.
more...
There is no doubt that medical science has achieved a number of mile stones, especially at the time of emergency but at the same time it is also true that its medication has a number of side effects. So at that moment stem cell therapy can be considered as a perfect solution that to without any medication. Thank you.
ReplyDeletestem cell treatment